Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 22, 2025

Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …

Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China
Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …

Global Drug Formulation Market to Hit USD 2.8 Trillion by 2035 Amidst Rising Demand for Advanced Oral Formulations | FMI
Comprehensive insights into the global Drug Formulation Market, highlighting growth trends, innovations, and future opportunities. NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The global drug formulation market is set for remarkable …

PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of a report examining Silexion Therapeutics, an innovative biotechnology company developing unique RNA interference (RNAi) therapies targeting KRAS-driven cancers. The …

Anti-Biofilm Wound Dressing Market Poised for Significant Growth to Reach USD 2,403.1 Million by 2035 a CAGR 9.8% | FMI
Rising demand for infection prevention drives growth in the global anti-biofilm wound dressing market, advancing wound care solutions worldwide NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The global anti-biofilm wound dressing market …

Pupillometer Market Set for Robust Growth with Cutting-Edge Technological Advances and Rising Clinical Demand | FMI
Rising Demand for Neurological Diagnostics Propels Growth in the Global Pupillometer Market NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- A growing tide of technological innovation, increasing prevalence of neurological and ophthalmic …

Global Wheelchair Market Set to Surpass USD 9,804.9 Million by 2034 Amidst Soaring Demand for Mobility Solutions | FMI
Global Wheelchair Market Set to Expand Significantly Through 2034 – Insights on Size, Share, Trends …

SOAX Acquires ProxyWow to Strengthen Infrastructure and Accelerate Access to Reliable Web Data at Scale
Strategic acquisition boosts SOAX’s infrastructure …

Citrin Foundation and University Children’s Hospital Zürich Launch First Center for Translational Research in UCD
Pioneering translational model combines cutting-edge science, clinical leadership, global collaboration, and a patient-first mission to unlock new therapies LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- The Citrin Foundation and the …

Recode Ventures' Vishal Gulati Elected Fellow Of Academy Of Medical Sciences For Contributions To Translational Medicine
Healthcare Venture Capitalist Vishal Gulati Inducted Into The Academy Of Medical Sciences In Recognition Of His Role In Translational Medicine. LONDON, UK, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- Recode Ventures is honoured to announce that …

Houston Emerges as Global Center for Brain Health Innovation
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Protecting and enriching human brain health and performance may be one of the most important economic strategies that businesses and governments pursue as they seek to strengthen workforces, mitigate the surging …

Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease
SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Endurance Bio Inc., a clinical-stage biotechnology company developing therapies for neurodegenerative and metabolic diseases, today announced that its compound, T-168, has been selected for testing on …

Creative Biolabs Introduces Game-Changing CRISPR Solutions for Accelerated Gene Therapy Development
By leveraging the potential of CRISPR gene editing technology, Creative Biolabs provides custom gene therapy development solutions to accelerate your research. SHIRLEY, NY, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The gene therapy landscape has …

Mobile Clinic Market is likely to reach USD 6.7 Billion by 2034 expanding at a CAGR of 7% | FMI
Explore growth trends, market share, and future projections for the global mobile clinic market from 2024 to 2034 NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The global mobile clinic market is undergoing a remarkable transformation. …

Newly Formed National Alliance Aims to Help Cities and States Combat Opioid Crisis and Improve Public Health Outcomes
Milwaukee, Wis., May 22, 2025 (GLOBE NEWSWIRE) -- In a timely effort to address the nation’s opioid epidemic, CMRignite, one of the nation’s leading cause marketing agencies, has launched a new national recovery alliance composed of trusted messengers, …

Celebrating 10 Years of National Deafblind Awareness Month in Canada
Newmarket, Ontario, Canada, May 22, 2025 (GLOBE NEWSWIRE) -- June 2025 marks a significant milestone—10 years since the Senate of Canada officially proclaimed June as National Deafblind Awareness Month. This anniversary is a powerful opportunity to …

CCRPS Achieves Prestigious CPD Accreditation Across All Eight Clinical Research Certification Programs
CCRPS, a leader in clinical research education, is pleased to announce that all eight of its comprehensive clinical research training programs OREM, UT, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The Certified Clinical Research Professionals …

Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older
Once-daily ZORYVE foam provides powerful clearance and rapid itch relief from head to toe with no limitation on duration of use More than half of the nearly 9 million people in the United States with plaque psoriasis experience scalp involvement Healthcare …

Global Lentiviral Vector Market Outlook 2025–2034: Drivers, Trends, Opportunities, and Growth Forecast
The Business Research Company's Global Lentiviral Vector Market Outlook 2025–2034: Drivers, Trends, Opportunities, and Growth Forecast LONDON, GREATER LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …